Morgan Stanley’s Pelagos Insurance Capital PLGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.6M Sell
518,646
-84,387
-14% -$1.84M ﹤0.01% 3511
2026
Q1
$11.5M Buy
603,033
+86,773
+17% +$1.66M ﹤0.01% 3455
2025
Q4
$10.1M Sell
516,260
-277,259
-35% -$5.17M ﹤0.01% 3606
2025
Q3
$14.4M Sell
793,519
-53,652
-6% -$895K ﹤0.01% 3208
2025
Q2
$14M Sell
847,171
-11,109
-1% -$184K ﹤0.01% 3136
2025
Q1
$13.9M Sell
858,280
-162,970
-16% -$2.61M ﹤0.01% 3050
2024
Q4
$18.5M Sell
1,021,250
-274,348
-21% -$5.09M ﹤0.01% 2824
2024
Q3
$23.4M Buy
1,295,598
+246,943
+24% +$4.36M ﹤0.01% 2647
2024
Q2
$17.1M Buy
1,048,655
+51,437
+5% +$911K ﹤0.01% 2833
2024
Q1
$19.4M Buy
997,218
+621,892
+166% +$9.16M ﹤0.01% 2730
2023
Q4
$4.76M Buy
375,326
+300,186
+400% +$4.03M ﹤0.01% 4407
2023
Q3
$1.1M Buy
+75,140
New +$1.05M ﹤0.01% 4738

Other funds holding PLGO

Morgan Stanley's PLGO Position: Q2 2026 in Review

Morgan Stanley reduced its Pelagos Insurance Capital (PLGO) stake by 14% in Q2 2026, selling an estimated $1.84M and leaving 518,646 shares worth $12.6M. The position accounts for ﹤0.01% of the portfolio, ranked #3511.

Morgan Stanley first reported a position in PLGO in Q3 2023 and has held it in 12 quarters since. The position peaked at $23.4M in Q3 2024. 172 funds tracked by Wall St. Rank hold PLGO as of Q2 2026.

  • Morgan Stanley held 518,646 shares of Pelagos Insurance Capital worth $12.6M as of Q2 2026.
  • Morgan Stanley sold 84,387 Pelagos Insurance Capital shares in Q2 2026, an estimated $1.84M.
  • Pelagos Insurance Capital made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #3511 holding.
  • Morgan Stanley first reported a position in Pelagos Insurance Capital in Q3 2023 and has held it in 12 quarters since.
  • Morgan Stanley's Pelagos Insurance Capital position peaked at $23.4M in Q3 2024.
  • 172 funds tracked by Wall St. Rank held Pelagos Insurance Capital as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.